Call now to secure your spot and receive $100 off your first appointment
Dose Flexibility Some providers offer more flexibility in dosing adjustments, potentially affecting pricing structures
Current FDA status Semaglutide (Ozempic/Wegovy) is patent-protected by Novo Nordisk (29 patents) until at least 2026
Heres what sets InjectCo apart as a physician-guided online weight loss program supported by licensed healthcare professionals
Manish Sahni, MD, provides comprehensive, physician-led guidance to ensure that your transition onto Wegovy (semaglutide) is safe, informed, and effective
Signs you may need a dose adjustment Contact your healthcare provider if you notice any of the following: Persistent mood changes or low energy after several weeks Ongoing side effects like insomnia, nausea, or restlessness Little or no change in appetite or weight despite consistent use (when using for off-label weight loss)